Corrigendum to "Targeting ERK1/2 protein-serine/threonine kinases in human cancers" [Pharmcol. Res. 142 (2019) 151-168]
- PMID: 30952557
- DOI: 10.1016/j.phrs.2019.03.019
Corrigendum to "Targeting ERK1/2 protein-serine/threonine kinases in human cancers" [Pharmcol. Res. 142 (2019) 151-168]
Erratum for
-
Targeting ERK1/2 protein-serine/threonine kinases in human cancers.Pharmacol Res. 2019 Apr;142:151-168. doi: 10.1016/j.phrs.2019.01.039. Epub 2019 Feb 20. Pharmacol Res. 2019. PMID: 30794926 Review.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous